Beijing Tiantan Biological Products Co., Ltd.
600161
Rank in Stocks
#4320
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Share Price
$1.81
Market Cap
$3.59B
Change (1 day)
-0.90%
Change (1 year)
-32.39%
Country
CN
Trade Beijing Tiantan Biological Products Co., Ltd. (600161)
Category
Healthcare
Stock price history for Beijing Tiantan Biological Products Co., Ltd. (600161)
Highest end of day price: $1.81 on 2026-10-01
Lowest end of day price: $0.07 on 2005-07-01
Lowest end of day price: $0.07 on 2005-07-01
Stock price history of Beijing Tiantan Biological Products Co., Ltd. from 2005 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -10.60% |
| 2025 | -18.04% |
| 2024 | -20.40% |
| 2023 | 33.59% |
| 2022 | -13.56% |
| 2021 | -28.42% |
| 2020 | 98.85% |
| 2019 | 45.59% |
| 2018 | -15.66% |
| 2017 | 10.41% |
| 2016 | 19.78% |
| 2015 | 5.68% |
| 2014 | 24.08% |
| 2013 | 90.14% |
| 2012 | -27.39% |
| 2011 | -24.78% |
| 2010 | -11.65% |
| 2009 | 89.78% |
| 2008 | -47.45% |
| 2007 | 135.81% |
| 2006 | 373.09% |
| 2005 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $756.75 | 7.56% |
CH
|
